Comparison of clinical efficacy between endoscope-assisted oblique lumbar interbody fusion and posterior lumbar interbody fusion in the treatment of lumbar degenerative diseases
By
Haoran Han
Can Cao
Zekai Sun
Wenyi Li
May 28, 2026
Clinical Scorecard: Evaluation of Clinical Outcomes: Endoscope-Assisted Oblique Lumbar Interbody Fusion Versus Posterior Lumbar Interbody Fusion for Lumbar Degenerative Disorders
At a Glance
Category Detail
Condition Lumbar Degenerative Diseases Key Mechanisms Endoscope-assisted oblique lumbar interbody fusion (Endo-OLIF) achieves direct and indirect spinal-canal decompression while preserving posterior structures. Target Population Patients aged 18–85 years with lumbar degenerative diseases unresponsive to conservative treatment. Care Setting Hebei General Hospital, January 2020 - December 2023
Key Highlights
Endo-OLIF demonstrated shorter operative time and less intra-operative blood loss compared to PLIF. Lower early post-operative VAS and ODI scores were observed in the Endo-OLIF group. Restoration of disc height and lumbar lordosis was significantly better in the Endo-OLIF group. No significant differences in complication rates or fusion rates between the two groups. Both procedures yielded satisfactory clinical outcomes for lumbar degenerative diseases. Guideline-Based Recommendations
Diagnosis
Diagnosis based on clinical symptoms and imaging examinations. Management
Endo-OLIF as a minimally invasive option for lumbar degenerative diseases. Monitoring & Follow-up
Follow-up duration of more than 12 months is recommended. Risks
Consideration of potential complications associated with both surgical techniques. Patient & Prescribing Data
62 patients with lumbar degenerative diseases.
Endo-OLIF offers advantages of minimal invasiveness and faster recovery.
Clinical Best Practices
Utilize endoscopic visualization for thorough exploration of the intervertebral space. Adopt a left-sided approach for Endo-OLIF to minimize surgical trauma. Related Resources & Content
